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ABSTRACT
Background: Diet may alter the configuration of gut microbiota, but the impact of prenatal and postnatal nutritional
interventions on infant gut microbiota has not been investigated.
Objective:We evaluated whether providing lipid-based nutrient supplements (LNSs) to mother–infant dyads promotes
a more diverse and mature infant gut microbiota, compared to maternal supplementation with multiple micronutrients
(MMN) or iron and folic acid (IFA).
Methods:We enrolled 869 pregnant women in a randomized trial in Malawi. There were 3 study groups, with women
receiving 1MMN capsule daily during pregnancy and 6mo postpartum, or 1 LNS sachet (20 g) daily during pregnancy and
6 mo postpartum, or 1 IFA capsule daily (during pregnancy) then a placebo daily (postpartum). Infants in the LNS group
received LNS from 6 to 18 mo; infants in the other groups did not receive supplements. The infants’ fecal microbiota
were characterized by PCR amplification and sequencing of the bacterial 16S rRNA gene (variable region 4). The primary
outcomes were microbiota α diversity and maturation [as microbiota-for-age z score (MAZ)]. Specific associations of
taxa with intervention were established with indicator species analysis (ISA).
Results: Primary outcomes did not differ between IFA andMMNgroups, so these groupswere combined (IFA+MMN).
Mean ± SD α diversity was higher in the LNS group at 18 mo for Shannon index [3.01 ± 0.57 (LNS) compared with
2.91 ± 0.60 (IFA + MMN), P = 0.032] and Pielou’s evenness index [0.61 ± 0.08 (LNS) compared with 0.60 ± 0.09
(IFA + MMN), P = 0.043]; no significant differences were observed at 1, 6, 12, or 30 mo. MAZ and β diversity did not
differ at any age. We found 10 and 3 operational taxonomic units (OTUs) positively associated with LNS and IFA + MMN,
respectively; however, these associations became nonsignificant following false discovery rate correction at 10%.
Conclusions: Prenatal and postnatal LNS intake promoted infant gut microbiota diversity at 18 mo, after 12 mo of child
supplementation, but did not alter microbiota maturation. This trial was registered at clinicaltrials.gov as NCT01239693.
J Nutr 2020;00:1–11.
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Introduction
Malnutrition is responsible for about 45% of deaths in children
globally (1), and is common in Sub-Saharan Africa (2). Among
the nutritional interventions to prevent maternal and child
undernutrition and micronutrient deficiencies (3), the provision
of small-quantity lipid-based nutrient supplements (SQ-LNSs)
to mothers during pregnancy and lactation, and to their infants
starting at 6 mo after birth is a relatively new strategy (4).
Two recent meta-analyses assessing the impact of SQ-LNS
supplementation have shown positive effects on birth outcomes
(5) and child growth (6), although there is heterogeneity among
trials.
Intake of nutrients and other food substances may influence
gut microbiota development, immunity, and metabolism in
both animals (7, 8) and humans (9–13), both positively and
negatively. For example, oligosaccharides present in human
milk, and to a lesser extent in bovine milk, can strongly
influence microbiota composition (14, 15). Gut microbes may
also respond differentially to the amounts and types of fat and
protein in the diet (16–18). Amounts of micronutrients may also
affect the microbial community. In Kenya, infants recruited at
age 6 mo and given nutritional supplements containing iron for
4 mowere shown to have an increased abundance of pathogenic
species and increased cases of intestinal inflammation (19). By
contrast, studies in Malawi revealed that iron-containing LNS
or corn-soya blend given to children did not have an impact
on the gut microbiota profile at age 18 mo (20, 21). A recent
study showed that growth of pathogens such Escherichia coli
and Salmonella typhimurium was significantly reduced when
independently cultured in an iron-deficient in vitro colonic
fermentation model (22). However, no reduction was observed
in growth of beneficial bacteria species such as Lactobacillus
rhamnosus (22).
The interventions in the 2 Malawian studies included LNS
supplementation to children only, with no prenatal component.
Maternal prenatal diet has recently been associated with infant
gut microbiota, depending on delivery mode (23). However, the
impact of LNS supplementation to both mothers and children
on the diversity and maturity of the gut microbiota has not
previously been explored.
This article reports secondary outcomes from a randomized
controlled clinical trial, the iLiNS-DYAD-M trial, which was
designed to study the health impacts of SQ-LNS when provided
to Malawian mothers during pregnancy and the first 6 mo
postpartum and to their newly born children from 6 to 18 mo
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of age (24). We have previously shown that provision of SQ-
LNS did not increase the mean birth length or weight in the full
study population, but that there may have been a modest impact
among selected subgroups (25). There was also no significant
impact on child growth at 18 mo (24). We report herein the
effects of the intervention on the children’s gut microbiota
composition and maturation.We tested the hypothesis that SQ-
LNS supplementation to both mothers and their infants would
lead to a more diverse and mature gut microbiota between
ages 1 and 30 mo, compared to maternal supplementation with
multiple micronutrients (MMN) during pregnancy and the first
6 mo of lactation only or iron and folic acid (IFA) during
pregnancy only. The hypothesis was based on the fact that LNS
containedMMNplus 4 additional minerals, protein and fat and
was administered to both mothers and their children, unlike IFA
or MMN which were given to mothers only.
Methods
Study setting and design
This study was part of a randomized, controlled, partially blinded,
parallel-group clinical trial known as the International Lipid-based
Nutrient Supplements DYAD (iLiNS-DYAD) trial. Details of the study,
including the original sample size calculation are described elsewhere
(25). Briefly, the iLiNS-DYAD trial was conducted in 2 hospitals and
2 health centers in a rural area in Mangochi district, Malawi, a setting
with high prevalence of infant stunting and underweight, and poor food
security. The trial enrolled 1391 pregnant mothers aged ≥15 y and
≥20 weeks of gestation from the antenatal clinics of the 2 hospitals
and 2 health centers (Figure 1). Women were excluded from the trial
if they had chronic medical conditions, pregnancy complications at
enrollment (moderate to severe edema, blood hemoglobin concentration
<50 g/L, systolic blood pressure >160 mmHg or diastolic blood
pressure >100 mmHg), were previously enrolled in iLiNS-DYAD, or
concurrently enrolled in another clinical trial.
All 1391 women enrolled were advised to consume supplements
until delivery, while a subset of 869 women were advised to continue
with the supplementation until 6 mo postpartum. The women were
randomized into the 3 intervention groups: iron-folic acid [IFA;
Nutrition Products South Africa (Pty) Ltd], multiple micronutrients
[MMN; Nutrition Products South Africa (Pty) Ltd], and small-quantity
lipid-based nutrient supplements (LNS; Nutriset S.A.S.) (25). In brief, an
independent researcher (not involved with the trial) created individual
randomization slips in blocks of 9. The slips were then packed in
sealed, numbered, and opaque randomization envelopes stored in
numerical order. The enrolled women were asked to choose 1 of the top
6 envelopes in the stack, and the contents of each chosen envelope
indicated her participant number and group allocation. Women in the
IFA group (n= 290) received 60 mg of iron and 400 μg of folic acid in a
capsule each day until delivery, followed by a placebo capsule (low dose
calcium) until 6 mo postpartum. Women in the MMN group (n = 291)
received 20 mg of iron, in addition to 400 μg of folic acid and 16
additional micronutrients each day until 6 mo postpartum. The IFA,
placebo, and MMN capsules were identical in appearance. Women in
the LNS group (n = 288) received a 20 g sachet of LNS each day until
6 mo postpartum. The LNS contained the same 18 micronutrients as the
MMN capsule, with 4 additional minerals, protein and fat (from milk,
peanuts, and soybean oil), and also provided 118 kcal of energy (25).
No supplementation was given to children in the IFA andMMNgroups,
whereas children in the LNS group received another formulation of
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FIGURE 1 Flow diagram of recruitment, enrollment, and follow-up of Malawian women and their infants who participated in the International
Lipid-Based Nutrient Supplements Project. ∗Death and drop out numbers are cumulative. LNS, lipid-based nutrient supplement.
LNS from 6 to 18 mo. The 20 g daily LNS ration given to children
was designed to meet micronutrient needs for healthy breastfeeding
children (4, 24). All children were followed-up for 30 mo from birth.
Supplements were delivered at the beginning of every 2-wk period. A
statistician not involved in the study maintained the intervention code,
which was not broken until all laboratory and statistical analyses were
performed. Data on adherence of participants to the study intervention
were recorded by counting the number of delivered and recovered
capsules or sachets (25).
Dietary characteristics at 18mowere assessed as reported previously
(26). Briefly, dietary diversity and consumption of micronutrient-rich
food groups were assessed through a guided free recall of liquids and
foods consumed by the child the previous day and a list-based recall
of the number of days each food group was consumed in the 7 d
preceding the interview. Dietary diversity score was calculated based
on report in 24-h recall (following WHO guidelines) as the sum of
yes/no consumption of 7 defined food groups (grains, roots, and tubers;
legumes and nuts; dairy products; flesh foods; eggs; vitamin A-rich fruits
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and vegetables; other fruits and vegetables), and consumption of animal-
source food groups yesterday was defined as having consumed ≥1 of
organ meats, other meat/poultry, fish, eggs, or dairy.
The baseline sociodemographic informationwas collected by trained
study personnel. The information gathered included age, household
assets, and HIV status.
An asset index for each household was constructed based on
ownership of a set of assets (radio, television, cell phone, bed, mattress,
bed-net, and bicycle), lighting source, drinking water supply, sanitation
facilities, and roofing materials. Household ownership of this set of
assets was then combined into an index (with a mean of zero and SD of
1) with principal components analysis (27). Maternal HIV status was
established with a whole-blood antibody rapid test (Alere Determine
HIV-1/2, Alere Medical Co, Ltd and Uni-Gold HIV; Trinity Biotech plc)
(25). Key details of the trial were recorded at the clinical trial registry
at the National Institutes of Health (USA) (clinicaltrials.gov), under the
registration number NCT01239693. The ethical clearance for the study
was granted by the University of Malawi College of Medicine Research
and Ethics Committee (COMREC) and the ethics committee at Tampere
University Hospital District, Finland.
Fecal sample collection
Fecal samples from participating children were collected by their
mothers in their homes at ages 1, 6, 12, 18, and 30 mo, generally early
in the morning, and at the end of every 2-wk supplementation delivery
period. The mothers were informed of the upcoming sample collection
visit and were provided with sample collection tubes the day before. On
the day of sample collection, the mothers were asked if the child was
passing normally formed feces (to exclude diarrhea). If diarrhea was
suspected (>3 stools a day and markedly more liquid), the sample was
not collected, and the visit was rescheduled for 2 wk later. Sample tubes
were collected on the day of sample collection, usually in the morning.
The tubes containing feces were sealed, labeled, and immediately stored
in a Ziploc bag on a frozen ice pack in a cooler bag. The samples were
subsequently transported to a satellite clinic and placed in a −20◦C
freezer for ≤2 d before being transported, frozen, to the central clinic
in Mangochi for storage at −80◦C. The samples were later packaged
and shipped on dry ice to the USA for culture-independent analysis
of community composition at Washington University, St. Louis, MO.
Sample collection spanned all the 3 seasons of Malawi: warm-wet
season, cool-dry-winter season, and hot-dry season.
DNA purification and 16S rRNA sequencing
Details of DNA purification and generation and sequencing of
amplicons produced from V4 of bacterial 16S rRNA genes have been
described previously (20). Stool samples were homogenized by grinding
in the presence of liquid nitrogen, followed by DNA extraction. DNA
libraries were prepared by amplifying the V4 region (∼255 bp) of the
16S rRNA gene. Purified DNA libraries were then sequenced on the
Illumina MiSeq platform. Sequence processing and picking of OTUs (at
97% sequence identity) were performed in QIIME (28). OTU data were
filtered with a threshold of at least 0.1% of reads in ≥2 samples. OTUs
are clusters of closely related sequences, at a defined similarity threshold
(29). The V4 16S rRNA sequence data generated in this study are
available through the European Nucleotide Archive (accession number
PRJEB29433).
Measurements of microbial maturity and diversity
Microbiota maturity was measured with a Random Forests machine-
learning model (30, 31). This model, generated from analysis of fecal
samples collected from members of a Malawian cohort from birth
through the second year of life, predicts microbiota age based on the
abundances of 25 age-discriminatory OTUs (30). Microbiota ages of
study members predicted by this model were compared to the median
microbiota age of chronologically age-matched children in the healthy
reference group to generate microbiota-for-age z scores (MAZ).
Microbiota diversity and MAZ scores were calculated with OTU
data that were rarefied to 5000 reads. Through use of the phyloseq
package in R (32),we calculated the Shannon diversity index to measure
the mean α diversity of OTUs in each sample. The Shannon index
considers both richness and evenness of OTUs in each sample. A larger
value indicates higher level of diversity (33). In addition, from the OTU
data, species richness and Pielou’s evenness function were calculated.
Faith’s phylogenetic diversity was calculated with the Picante R Package
(34).We also measured β diversity with the Bray-Curtis metric (35) and
tested whether samples were more similar within treatment groups than
between groups. α Diversity, microbiota maturity (MAZ scores), and β
diversity outcomes were assessed at 1, 6, 12, 18, and 30 mo.
Statistical analysis
The primary analysis was based on the intention to treat principle.
Our statistical analysis plan, posted at https://ilins.ucdavis.edu before
beginning the analysis, specified that the analysis would first be
performed with all 3 treatment groups, and if there was no difference
between the IFA and MMN groups (in which no supplements were
provided directly to the children), those 2 groups would be combined
and the analyses would be repeated to test for differences between
the LNS group and the other 2 groups combined. For the Shannon
index, species richness, Pielou’s evenness function, Faith’s phylogenetic
diversity and MAZ, outliers below the 2.5th percentile were truncated
to the 2.5th percentile and outliers above the 97.5th percentile were
truncated to the 97.5th percentile (36, 37). The primary analysis was
completed with truncated outcome data, but a sensitivity analysis was
performed with nontruncated data.
We first performed ANCOVA testing of differences between
intervention groups, including child’s age at measurement as a control
covariate in every model. Additional adjustment covariates were
included in adjusted models if they were related to the outcome when
tested individually (P < 0.1). We tested the null hypothesis of no
difference between the intervention groups with ANCOVA for all the
outcomes.
The covariates considered were maternal HIV status at enrollment,
season at time of stool sample collection, household assets z score at
enrollment, and infant age at time of measurement. Potential effect
modifiers were assessed with an interaction term in the ANCOVA. The
potential effect modifiers were season at time of measurement, age at
time of measurement,HIV status at baseline, and asset index at baseline.
The 3 Malawian seasons include: warm-wet season (November–April);
cool, dry winter season (May–August), and hot dry season (September–
October) (38). Significant interactions (P< 0.05) were further examined
with estimation of adjusted means within each category of the
categorical effect modifier (HIV status and season) and at the 10th and
90th percentiles of the continuous effect modifier (age and household
assets score), to understand the nature of the effect modification.
Differences in bacterial community composition between groups (β
diversity) were assessed based on permutational multivariate analysis
of variance (PERMANOVA) with distance matrices and permutation
tests, and analysis of similarities (ANOSIM) (39, 40). To identify taxa
that were significantly associated with a given nutritional intervention
at each age, we conducted indicator species analyses (ISA). ISA
identifies taxa that are statistically associated with an experimental or
observational grouping with the indicator species value, the product of
the probability that a given taxon is found in a sample belonging to a
particular intervention group (fidelity), and the conditional probability
that if the taxon is found, the sample in which it is found belongs to a
particular intervention group (specificity) (41). Statistical significance
of observed indicator species values was established by permutation
tests, and P values were corrected for multiple comparisons with the
Benjamini-Hochberg (BH) procedure at 10% false discovery rate.
Results
Study profile and follow-up outcome
Enrollment of pregnant women to the iLiNS-DYAD trial started
on February 17, 2011 and was completed in August 2012. Out
of the 869 mothers assigned to follow-up to 30 mo (Figure 1),
760 singleton live births were reported. The women who were
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not included experienced abortions/stillbirths (n= 20), dropped
out of the study (n = 69), or gave birth to twins (n = 20). At
18 mo, 622 children completed anthropometric measurements
and the rest (n = 138) were lost to follow-up. At 30 mo,
575 children completed anthropometric measurements. Stool
samples were collected from 331 children at 1 mo, 515 at 6 mo,
630 at 12 mo, 622 at 18 mo, and 575 at 30 mo. We completed
the 18-mo follow-up in April 2014 and the 30-mo follow-up in
April 2015.Approximately 7%of visits were rescheduled across
the sampling points between 1 and 18mo of age. Loss to follow-
up at all timepoints was similar across intervention groups. The
mean adherence to the intervention was estimated at over 80%
in all the groups (25).
Study characteristics
At baseline, the distributions of maternal age at enrollment,
household assets, and gestational age at birth were similar
across intervention groups. The proportion of HIV positive
mothers did not differ by intervention group, nor did the season
at enrollment. The maternal age at enrollment and household
assets z score at baseline for mothers excluded from this sub-
study and for mothers included in the study were similar;
however, gestational age at birth was slightly lower among those
excluded (39.4 compared with 39.6 wk, P = 0.03) and HIV
positive status was slightly less prevalent among those excluded
(84% compared with 88%, P = 0.04). Indicators of dietary
intake (at 18 mo) were not different by intervention (Table 1).
Antibiotic use was rare, with reported use on ∼1% of observed
days based on recall data collected during weekly home
visits (24).
Effect of intervention on microbiota characteristics
Our findings showed no significant differences in the microbiota
diversity or MAZ scores between the IFA and MMN groups
at any time point (Supplemental Table 1). Therefore, the
IFA and MMN groups were combined into 1 control group
(IFA + MMN) and the analyses repeated to test for differences
between the LNS and control groups.
α Diversity.
In the entire cohort of children, Shannon diversity index
increased with age, with the mean ± SD values being
0.92 ± 0.50, 1.60 ± 0.59, 2.40 ± 0.65, 2.94 ± 0.59, and
3.53 ± 0.42 at 1, 6, 12, 18, and 30 mo, respectively. At
18 mo (at which point children had received LNS for 1 y),
there was a difference of 0.10 in the mean α diversity values
between the LNS and control groups (3.01 ± 0.57 compared
with 2.91 ± 0.60, P = 0.032) (Table 2). Similarly, Pielou’s
evenness function was significantly higher in the LNS group
than in the IFA + MMN group (P = 0.043) at 18 mo. There
was a trend for species richness to be higher in the LNS group
than in the IFA + MMN group (P = 0.08) at 18 mo. There
was no significant difference in Faith’s phylogenetic diversity
at 18 mo between treatment groups (P = 0.19). At other
ages [1 and 6 mo (without LNS supplementation); 12 mo
(with LNS supplementation for half a year); and 30 mo (with
children no longer supplemented for a year)], there were no
significant differences between the groups in Shannon index,
Faith’s phylogenetic diversity, Pielou’s evenness function, or
species richness.
Regarding potential effect modifiers, season at the time
of sample collection modified the association between dietary
intervention and microbial diversity at ages 6 and 12 mo. At
6 mo, Shannon diversity and Pielou’s evenness were significantly
higher in the LNS group compared with the IFA + MMN TA
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TABLE 2 Infant gut microbiota characteristics by intervention group at 1 mo, 6 mo, 12 mo, 18 mo, and 30 mo1
Microbiota characteristics Time IFA + MMN LNS
IFA + MMN compared
with LNS P 2
Shannon diversity index 1 mo 0.88 ± 0.60 (225)3 0.99 ± 0.53 (106) 0.10 (−0.03, 0.22) 0.12
6 mo 1.60 ± 0.66 (347) 1.59 ± 0.69 (168) − 0.01 (−0.11, 0.10) 0.86
12 mo 2.39 ± 0.65 (419) 2.45 ± 0.72 (211) 0.01 (−0.10, 0.12) 0.90
18 mo 2.91 ± 0.60 (414) 3.01 ± 0.57 (208) 0.11 (0.01, 0.21) 0.03
30 mo 3.51 ± 0.47 (382) 3.58 ± 0.43 (193) 0.07 (−0.00, 0.14) 0.06
Pielou’s evenness function 1 mo 0.25 ± 0.13 (225) 0.26 ± 0.13 (106) 0.01 (−0.01, 0.04) 0.32
6 mo 0.39 ± 0.12 (347) 0.39 ± 0.12 (168) 0.00 (−0.03, 0.02) 0.76
12 mo 0.52 ± 0.11 (413) 0.53 ± 0.12 (206) 0.00 (−0.02, 0.02) 0.83
18 mo 0.60 ± 0.09 (414) 0.61 ± 0.08 (208) 0.02 (0.00, 0.03) 0.04
30 mo 0.66 ± 0.06 (378) 0.67 ± 0.05 (192) 0.01 (−0.01, 0.02) 0.10
Faith’s phylogenetic diversity 1 mo 6.45 ± 1.86 (225) 6.79 ± 1.93 (106) 0.34 (−0.10, 0.77) 0.13
6 mo 11.15 ± 4.80 (347) 11.24 ± 5.17 (168) 0.00 (−0.82, 1.00) 0.84
12 mo 16.33 ± 5.30 (404) 16.41 ± 5.58 (198) 0.09 (−0.79, 1.02) 0.85
18 mo 21.30 ± 6.67 (414) 22.06 ± 7.05 (208) 0.76 (−0.38, 1.89) 0.19
30 mo 30.75 ± 7.85 (378) 31.28 ± 6.90 (192) 0.67 (−0.78,1.84) 0.43
Species richness 1 mo 32.5 ± 10.9 (225) 34.8 ± 12.6(106) 2.22 (−0.44, 4.87) 0.10
6 mo 60.3 ± 25.3 (347) 59.4 ± 24.0 (168) − 0.84 (−5.43, 3.76) 0.72
12 mo 97.8 ± 39.3 (414) 98.0 ± 40.4 (206) 0.18 (−6.47, 6.83) 0.96
18 mo 134.9 ± 51.6 (414) 142.9 ± 55.4 (208) 7.97 (−0.85, 16.79) 0.08
30 mo 214.4 ± 60.9 (378) 219.8 ± 54.7 (192) 5.39 (−4.86, 15.64) 0.30
MAZ4 1 mo NA NA NA NA
6 mo 0.63 ± 2.39 (347) 0.40 ± 2.47 (168) − 0.23 (−0.66, 0.20) 0.30
12 mo − 0.33 ± 2.52 (419) − 0.27 ± 2.80 (211) 0.06 (−0.36, 0.49) 0.77
18 mo − 1.37 ± 1.70 (414) − 1.27 ± 1.81 (208) 0.10 (−0.19, 0.39) 0.49
30 mo − 3.70 ± 2.37 (382) − 3.50 ± 2.43 (193) 0.19 (−0.21, 0.62) 0.35
1Values are means ± SDs (n) or mean differences (95% CI). IFA + MMN, iron and folic acid + multiple micronutrients; LNS, lipid-based nutrient supplement; MAZ,
microbiota-for-age z score; NA, not applicable.
2P values obtained from ANCOVA.
3Number of infants at each sampling time point stratified by intervention group.
4No data for the calculation of MAZ were available at 1 mo.
group (P = 0.012, 0.042, respectively) in the hot-dry season,
but they were lower in the LNS group in the cool, dry winter
(P < 0.05, < 0.01, respectively), and there was no significant
group difference during the warm-wet season (P = 0.77,
0.85, respectively) (Figure 2). At 12 mo, species richness and
phylogenetic diversity were higher in the LNS group (compared
with the IFA + MMN group, P = 0.019 and P = 0.012,
respectively) in the cool, dry season but not in the other
2 seasons (Figure 3).
Household asset z score modified the association between
the intervention group and diversity at 30 mo: among children
in households with higher asset scores, Shannon diversity index
was significantly higher in those who received LNS compared
with IFA + MMN (P < 0.001), whereas no differences
were observed among children in households with lower asset
scores (Figure 4). A similar pattern was observed for Faith’s
phylogenetic diversity, Pielou’s evenness index, and species
richness at 30 mo.
β Diversity.
Based on PERMANOVA and ANOSIM, we did not detect
any significant effects of LNS intervention on the bacterial
composition of the microbiota in any age group (P > 0.05;
Supplemental Figure 1). However, significant effects of age
on bacterial community composition were detected by both
PERMANOVA (R2 = 0.32, pseudo-F = 314, P < 0.001) and
ANOSIM (R = 0.4514, P < 0.001) (Supplemental Figure 2).
Microbiota maturity.
In the entire cohort of children, MAZ declined with age, with
the mean ± SD MAZ scores being 0.64 ± 2.41, −0.28 ± 2.57,
−1.32 ± 1.72, and −3.69 ± 2.33 at 6, 12, 18, and 30 mo,
respectively. There were no significant differences in MAZ
between the intervention groups at any age when this metric
was calculated (Table 2), and no significant effect modifiers. The
MAZ metric was not calculated for samples at 1 mo because of
the low sample size at this age in the healthy reference control
cohort that was used to generate the Random Forests-derived
model.
Taxa distribution profile.
The taxonomic profile (at genus level) and the corresponding
relative abundances were similar by intervention group at
each age (Supplemental Figure 3). However, the number of
genera detected increased with age, accompanied by an increase
or decrease in the abundances of specific genera. The most
abundant genus at 1 mo (Bifidobacterium, predominantly
Bifidobacterium longum species) gradually decreased with age
to become 1 of the least abundant species at 30 mo. At
the same time, the abundance of Prevotella (predominantly
Prevotella copri species) increased with age, emerging as 1 of
the most abundant species at 30 mo. Although the abundance
of Streptococcus remained relatively stable with age, the
abundance of Faecalibacterium was seen to increase from 6 up
to 30 mo.
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FIGURE 2 Shannon index (A) and Pielou’s index (B) at 6 mo as a
function of season at the time of sample collection by intervention
group. Sample sizes for IFA + MMN compared with LNS groups
were as follows: warm-wet season (246 compared with 118), cool-dry
season (129 compared with 71), and hot-dry season (101 compared
with 47). ∗IFA + MMN and LNS groups differ, P < 0.05. ∗∗IFA + MMN
and LNS groups differ, P < 0.01. IFA, iron and folic acid; LNS, lipid-
based nutrient supplement; MMN, multiple micronutrients.
Indicator species analysis.
To identify taxa whose abundances differed between the
2 intervention arms, we conducted ISA at OTU level at
each age (Figure 5). At 1 mo there was only 1 indicator
OTU (OTU_8,258,081),which belonged to theBifidobacterium
genus. At 6 mo we detected 1 indicator OTU (OTU_4,481,613),
which belonged toCollinsella aerofaciens species. These 2OTUs
belonged to phylum Actinobacteria and were both significantly
positively associated with LNS intervention. Whereas no
indicator OTUs were detected at 12 mo, we detected 9 indicator
OTUs 18 mo and 2 at 30 mo. All the 9 indicator OTUs detected
at 18 mo belonged to the phylum Firmicutes; for 7 of these
OTUs, prevalence was higher in the LNS group (these OTUs
included genera Clostridium, Eubacterium, Coprococcus, and
Faecalibacterium prausnitzii species), while for 2 OTUs (repre-
senting Clostridium and Lactobacillus ruminis), prevalence was
higher in the control group. Of the 2 indicator OTUs at 30 mo,
1 was significantly positively associated with the LNS in-
tervention (OTU_3,264,821, a Prevotella genus belonging to
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FIGURE 3 Species richness (A) and phylogenetic diversity (B) at
12 mo as a function of season at the time of sample collection by
intervention group. Sample sizes for IFA + MMN compared with LNS
groups were as follows: warm-wet season (246 compared with 118),
cool-dry season (129 compared with 71), and hot-dry season (101
compared with 47). ∗IFA + MMN and LNS groups differ, P < 0.05.
IFA, iron and folic acid; LNS, lipid-based nutrient supplement; MMN,
multiple micronutrients.
Bacteroidetes phyla) and the other with the control group
(OTU_4,453,501, a Veillonella atypica species belonging to
Firmicutes phyla). However, following BH correction at 10%
false discovery rate, none of the observed associations remained
significant.
Discussion
We tested the hypothesis that supplementation with LNS to
mothers during pregnancy and the first 6 mo postpartum and
to infants between the ages of 6 and 18 mo would lead to a
more diverse or mature gut microbiota between the ages of 1 mo
and 30 mo, compared to supplementation with MMN during
pregnancy and the first 6 mo postpartum only, or IFA during
pregnancy only. α Diversity (based on the Shannon diversity
index and Pielou’s evenness) was higher in the LNS group at age
18mo but no group differences were observed at ages 1, 6, 12, or
30 mo. There was no significant difference between intervention
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FIGURE 4 Shannon index at 30 mo as a function of baseline asset
index percentile by intervention group. Sample sizes for IFA + MMN
compared with LNS groups were as follows: below 90th percentile
(351 compared with 170) and above 90th percentile (26 compared
with 20). ∗∗∗IFA + MMN and LNS groups differ, P < 0.001. IFA, iron
and folic acid; LNS, lipid-based nutrient supplement; MMN, multiple
micronutrients.
groups in species richness, Faith’s phylogenetic diversity, or
microbiota maturity as determined by MAZ score at any age. β
Diversity (based on Bray-Curtis dissimilarity) was not affected
by the intervention, although a distinct clustering was observed
by age group.Through use of ISA,we established associations of
certain taxa at OTU level with intervention group (IFA+MMN
or LNS) at 6, 12, 18, and 30 mo; however, these did not remain
significant following BH correction.
Strengths of this study include random allocation of study
participants to intervention groups, blinding of the outcome
assessors to the intervention, training of research personnel
in good clinical practices, and a high level of standardization
and quality assurance during data collection. One of the
limitations was that there were temporary interruptions of the
LNS distribution during the trial, partly because of temporary
migration out of the study area and inability of the research
personnel to locate the participant(s) during active farming
periods. However, the interruptions were not major, and the
proportion of missing participants did not differ between
groups. A potential source of bias is that there were statistically
significant differences in 2 baseline characteristics (gestational
age at birth, HIV status) between included and excluded
participants. However, the difference of 0.2 wk in gestational
age was small and these characteristics were not related to
the main microbiota outcomes (α diversity and MAZ), so our
findings should be generalizable to the study population. Sample
handling may affect the profile of fecal microbiota, especially if
immediate storage at −80◦C is not feasible (42). Time between
sample collection and storage would have differed by child-
specific logistical constraints and may affect results; however,
data collector blinding prevents these differences from being
systematic by intervention group.
The significant difference in α diversity measured by
Shannon index (LNS > control group) and by Pielou’s index
(LNS > control group) at 18 mo but not at 1 or 6 mo would
suggest that the maternal component of the intervention did
not have a detectable influence on the child’s microbiota. By
18 mo, the children in the LNS group had received supplements
for 1 y, while at 30 mo they had been without supplementation
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Actinobacteria; Bifidobacterium; OTU4347159
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FIGURE 5 Indicator species analysis at genus level by intervention at 1 mo, 6 mo, 12 mo, 18 mo, and 30 mo. The size of each square is
proportional to the size of the indicator species value metric. Sample sizes at each time point for the IFA + MMN compared with LNS groups
were as follows: 1 mo (225 compared with 106), 6 mo (347 compared with 168), 12 mo (419 compared with 211), 18 mo (414 compared with
208), and 30 mo (382 compared with 193). () IFA + MMN and LNS groups differ, P < 0.05 (before the Benjamini-Hochberg correction). IFA, iron
and folic acid; LNS, lipid-based nutrient supplement; MMN, multiple micronutrients.
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for 1 y. Thus, it is not surprising that the overall difference in
α diversity between supplementation groups would be seen at
18 mo but not at 30 mo, although it is also possible that the
difference at 18 mo was a random finding. The fact that we saw
no difference in α diversity at 12 mo suggests that 6 mo of LNS
was insufficient to change this outcome. By 30 mo, other factors
may have attenuated the difference that was evident at 18 mo.
Such factors may include the cessation of breastfeeding and
increased consumption of solid foods, which have been linked
to changes in microbial community composition between 9 and
18 mo (43).
Season appeared to modify the association of intervention
with certain outcomes at 6 and 12mo.At 6mo, there was higher
α diversity (Shannon and Pielou’s indices) in the LNS group than
in the IFA+MMN group during the hot-dry season, whereas in
the cool-dry season, α diversity was higher in the IFA + MMN
group than in the LNS group. The potential mechanism by
which maternal LNS consumption might influence the child’s
microbiome diversity in different ways in the hot-dry compared
with cool-dry seasons is unclear, given that no significant
impact of the intervention on bioactive breast milk proteins
or oligosaccharides at 6 mo was reported (44). At 12 mo,
the pattern was different from that observed at 6 mo: species
richness and phylogenetic diversity were higher in the LNS
group (compared to the IFA + MMN group) during the cool-
dry season,with no differences observed in the hot-dry or warm-
wet seasons. Thus, the interactions between season and the LNS
intervention are difficult to explain and could be a result of
chance.
Household wealth, as measured by the assets score, appeared
to modify whether the intervention was associated with
microbial diversity at 30 mo: among children in households
with greater assets, all 4 indices of diversity were higher in the
LNS group compared to the IFA + MMN group, whereas no
differences were observed among children in poorer households.
There is a possibility that weaning and dietary intake contribute
to the effect modification by socioeconomic status observed
at 30 mo. We do not have dietary data at 30 mo, but at
18 mo, children in households with assets scores above the
median were less likely to still be breastfed (85% compared with
94%) and had better quality diets in terms of dietary diversity
and consumption of animal-source foods (data not shown).
Previous studies have shown that higher bacterial diversity
is associated with lower socioeconomic status among pre-
adolescents in Malaysia (45) and children aged <5 y in Kenya
(46). The higher microbial diversity among children of poorer
households may mask the effect of LNS intervention in our
setting.
The LNS intervention was associated with the abundance of
certain OTUs at 1, 6, 18, and 30 mo but the differences were
not statistically significant following correction for multiple
hypothesis testing. This is generally consistent with findings
from an earlier study in Malawi (20), which showed that
supplementation of children with LNS, or corn-soya blend
for 12 mo, did not affect microbiota composition at 6 or
18 mo of age. Another study in which Malawian children aged
6 mo received LNS for 6 mo also reported no effect of LNS
intervention on the prevalence or counts of Bifidobacterium in
children aged 12 mo (21). In all studies conducted in Malawi
(including this study), breastfeeding was universal and typically
of long duration, which may reduce the likelihood of detecting
effects of a nutrition intervention.
OTUs representing genera such as Shigella, Escherichia, or
Salmonella, which may be pathogenic, were detected at low
abundance levels in our study. These OTUs did not show
any association with either IFA + MMN or LNS at any
age even before correction for multiple hypothesis testing,
which is consistent with previous findings from the same
setting (20). In Kenya (19), supplementation with iron-fortified
micronutrient powder [MNP, containing iron as sodium iron
EDTA (NaFeEDTA, ± 2.5 mgFeMNP)] was associated with
an increase in Escherichia coli and Shigella. Our trial used
LNS rather than MNP, but it is also possible that variations
in the formulation and amount of iron provided accounts for
the different findings, as the Malawian children received less
iron per dose (6 mg) than that provided in the Kenyan study
(12.5 mg) (19).
The increase in α diversity with age is consistent with findings
from a longitudinal study of Norwegian children (47). The
differences in composition by age category are also consistent
with other results demonstrating the development of a more
stable microbial community over time (47). By contrast, the
MAZ score decreased with age, suggesting worsening relative
microbiota maturity in this cohort of Malawian children, which
parallels the worsening of height-for-age z scores (48).
We conclude that providing LNS to mothers during preg-
nancy and 6mo postpartum and to their infants from 6 to 18mo
promotes infant gut microbiota diversity at 18 mo, and that a
persistent effect of the intervention 12 mo postsupplementation
may be evident depending on the participants’ socioeconomic
status. The findings did not support the hypothesis that LNS
supplementation will promote gut microbiota maturity in
Malawian infants. Changes in microbial diversity may lead to
changes in the functional capacity of the microbial community
(49), but whether greater diversity would affect biological
processes mediated by these microorganisms remains largely
unknown. Recently, we showed that microbiota diversity and
maturity were related to growth in weight; however, their
impact on inflammation was inconclusive (50), necessitating the
need for further investigation.
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